Breast Cancer Association with CYP1A2 Activity and Gene Polymorphisms - a Preliminary Case-control Study in Tunisia |
Ayari, I
(Metabolic Biophysics and Applied Pharmacology Laboratory, Department of Biophysics, Faculty of Medicine, University of Sousse)
Arnaud, MJ (Nutrition & Biochemistry) Mani, A (Metabolic Biophysics and Applied Pharmacology Laboratory, Department of Biophysics, Faculty of Medicine, University of Sousse) Pavanello, S (Occupational Health Section, Department of Cardiological, Thoracic and Vascular Sciences, University of Padova) Saguem, S (Metabolic Biophysics and Applied Pharmacology Laboratory, Department of Biophysics, Faculty of Medicine, University of Sousse) |
1 | Agundez JA (2004). Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab, 5, 211-24. DOI |
2 | Ahlbom A, Lichtenstein P, Malmstrom H, et al (1997) Cancer in twins: genetic and nongenetic familial risk factors. J Natl Cancer Inst, 89, 287-93. DOI |
3 | Arnaud MJ (2011). Pharmacokinetics and metabolism of natural methylxanthines in animal and man. Handb Exp Pharmacol, 200, 33-91. DOI |
4 | Bageman E1, Ingvar C, Rose C, Jernstrom H (2008) Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer Epidemiol Biomarkers Prev, 17, 895-901. DOI |
5 | Bchir F, Dogui M, Ben Fradj R, Arnaud MJ, Saguem S (2006). Differences in pharmacokinetic and electroencephalographic responses to caffeine in sleep-sensitive and non-sensitive subjects. C R Biol, 329, 512-9. DOI |
6 | Callahan MM, Robertson RS, Arnaud MJ, et al (1982). Human metabolism of [] and [] caffeine after oral administration, Drug Metabolism Disposition, 4, 417-23. |
7 | Caubet MS, Elbast W, Dubuc MC, Brazier JL (2002). Analysis of urinary caffeine metabolites by HPLC-DAD: the use of metabolic ratios to assess CYP1A2 enzyme activity. J Pharm Biomed Anal, 27, 261-70. DOI |
8 | Chang-Claude J, Beckmann L, Corson C, et al ; MARIEGENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2010). Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat, 119, 463-74. DOI |
9 | DeBruin LS, Josephy PD (2002). Perspectives on the chemical etiology of breast cancer. Environ Health Perspect, 110, 119-28. |
10 | Djordjevic N, Ghotbi R, Jankovic S, Aklillu E (2010) Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism. Eur J Clin Pharmacol, 66, 697-703. DOI |
11 | Evans MD, Butler JM, Nicoll K, Cooke MS, Lunec J (2003). 17 beta-Oestradiol attenuates nucleotide excision repair. FEBS Lett, 535, 153-8. DOI |
12 | Grant DM, Tang BK, Kalow W (1984). A simple test for acetylator phenotype using caffeine. Br J Clin Pharmacol, 17, 43-50. DOI |
13 | Hein DW, Doll MA, Fretland AJ, et al (2000). Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev, 9, 29-42. |
14 | Hong C, Tang BK, Hammond GL, et al (2004). Cytochrome P450 1A2 (CYP1A2) activity and risk factors for breast cancer: a cross-sectional study. Breast Cancer Res, 6, R352-65. DOI |
15 | Khvostova EP, Pustylnyak VO, Gulyaeva LF (2012). Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer. Genet Test Mol Biomarkers, 16, 167-73. DOI |
16 | Kotsopoulos J, Ghadirian P, El-Sohemy A, et al (2007). The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev, 16, 912-6. DOI |
17 | Lee HJ, Wu K, Cox DG, et al (2013). Polymorphisms in xenobiotic metabolizing genes, intakes of heterocyclic amines and red meat, and postmenopausal breast cancer. Nutr Cancer, 65, 1122-31. DOI |
18 | Long JR, Egan KM, Dunning L, et al (2006) Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet Genomics, 16, 237-43. DOI |
19 | Le Marchand L, Donlon T, Kolonel LN, Henderson BE, Wilkens LR (2005). Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 14, 1998-2003. DOI |
20 | Long JR, Cai Q, Shu XO, et al (2007). Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival. Pharmacogenet Genomics, 17, 331-8. DOI |
21 | Lichtenstein P, Holm NV, Verkasalo PK, et al (2000) Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med, 343, 78-85. DOI |
22 | MacLeod SL, Nowell S, Massengill J, et al (2000). Cancer therapy and polymorphisms of cytochromes P450. Clin Chem Lab Med, 38, 883-7. |
23 | Missaoui N, Landolsi H, Jaidaine L, et al (2012). Breast cancer in central Tunisia: an earlier age at diagnosis and incidence increase over a 15-year period. Breast J, 18, 289-91. DOI |
24 | Missaoui N, Trabelsi A, Parkin DM, et al (2010) Trends in the incidence of cancer in the Sousse region, Tunisia, 1993-2006. Int J Cancer, 127, 2669-77. DOI |
25 | Mrizak D, B'chir F, Jaidane M, Arnaud MJ, Saguem S (2011). Effects of changes in smoking habits on bladder cancer incidence in Tunisia. Health, 3, 613-9. DOI |
26 | Nakajima M, Yokoi T, Mizutani M, et al (1999). Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem, 125, 803-8. DOI |
27 | Shimada N, Iwasaki M, Kasuga Y, et al (2009). Genetic polymorphisms in estrogen metabolism and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians. J Hum Genet, 54, 209-15. DOI |
28 | Qiu LX, Yao L, Mao C, et al (2010). Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects. Breast Cancer Res Treat, 122, 521-5. DOI |
29 | Rebbeck TR, Troxel AB, Walker AH, et al (2007). Pairwise combinations of estrogen metabolism genotypes in postmenopausal breast cancer etiology. Cancer Epidemiol Biomarkers Prev, 16, 444-50. DOI |
30 | Sangrajrang S, Sato Y, Sakamoto H, et al (2009). Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int J Cancer, 125, 837-43. DOI |
31 | Singh V, Upadhyay G, Rastogi N, Singh K, Singh MP (2011). Polymorphism of xenobiotic-metabolizing genes and breast cancer susceptibility in North Indian women. Genet Test Mol Biomarkers, 15, 343-9. DOI |
32 | Tanaka E, Ishikawa A, Yamamoto Y, et al (1992). A simple useful method for the determination of hepatic function in patients with liver cirrhosis using caffeine and its three major dimethylmetabolites. Int J Clin Pharmacol Ther Toxicol, 30, 336-41. |
33 | Tian Z, Li YL, Zhao L, Zhang CL (2013). Role of CYP1A2 1F polymorphism in cancer risk: evidence from a meta-analysis of 46 case-control studies. Gene, 524, 168-74. DOI |
34 | Turesky RJ (2004). The role of genetic polymorphisms in metabolism of carcinogenic heterocyclic aromatic amines. Current Drug Metabolism, 5, 169-80 DOI |
35 | van Schaik RH (2008). CYP450 pharmacogenetics for personalizing cancer therapy. Drug Resistance Updates, 11, 77-98. DOI |
36 | Zhenzhen L, Xianghua L, Ning S, et al (2013). Current evidence on the relationship between three polymorphisms in the CYP1A2 gene and the risk of cancer. Eur J Cancer Prev, 22, 607-19. DOI |
37 | Williams JA, Phillips DH (2000). Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer. Cancer Res, 60, 4667-77. |
38 | Zheng W, Gustafson DR, Sinha R, et al (1998). Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst, 90, 1724-9. DOI |